RISCK is a multi-centre randomised controlled dietary intervention in subjects at increased risk of metabolic syndrome that compares the effects of diets with a reduced SFA content that vary according to total fat, MUFA content and glycaemia index (GI) (1) . The results are reported for changes in serum lipids among the participants who completed the 6-month dietary intervention (2) Baseline serum lipid measurements were undertaken for all subjects, subsequently all subjects followed a high-SFA (HS) diet for 1 month, after which period a further set of lipid measurements were completed. The mean serum cholesterol concentration (mmol/l) was 5.59 (SD 0.94) at screening and 5.61 (SD 0.97) at the end of the run-in period. The subjects were then randomized to one of five dietary interventions for a 6-month period: an HS-high-GI (HGI) similar to the run-in diet or one of four isoenergetic interventions (high-MUFA (HM)-HGI; HM-low-GI (LGI); low-fat (LF)-HGI; LF-LGI). The target intake for total fat was 38 % energy ( %E) in the HS and HM diets and 28 %E in the LF diets. The HM and LF diets were designed to reduce dietary SFA to 10 %E with a planned MUFA intake of 18 %E in the HM diets. The target GI differential between the HGI and LGI groups was approximately 12 points. Serum lipid concentrations were determined in a single laboratory following run-in and at the end of the intervention. Table. Mean change in serum lipids (mmol/l)* HS-HGI (n 83) HM-HGI (n 109) HM-LGI (n 114) LF-HGI (n 112) LF-LGI (n 120) P Mean 95 % CI Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
RISCK is a multi-centre randomised controlled dietary intervention in subjects at increased risk of metabolic syndrome that compares the effects of diets with a reduced SFA content that vary according to total fat, MUFA content and glycaemia index (GI) (1) . The results are reported for changes in serum lipids among the participants who completed the 6-month dietary intervention (2) Baseline serum lipid measurements were undertaken for all subjects, subsequently all subjects followed a high-SFA (HS) diet for 1 month, after which period a further set of lipid measurements were completed. The mean serum cholesterol concentration (mmol/l) was 5.59 (SD 0.94) at screening and 5.61 (SD 0.97) at the end of the run-in period. The subjects were then randomized to one of five dietary interventions for a 6-month period: an HS-high-GI (HGI) similar to the run-in diet or one of four isoenergetic interventions (high-MUFA (HM)-HGI; HM-low-GI (LGI); low-fat (LF)-HGI; LF-LGI). The target intake for total fat was 38 % energy ( %E) in the HS and HM diets and 28 %E in the LF diets. The HM and LF diets were designed to reduce dietary SFA to 10 %E with a planned MUFA intake of 18 %E in the HM diets. The target GI differential between the HGI and LGI groups was approximately 12 points. Serum lipid concentrations were determined in a single laboratory following run-in and at the end of the intervention. The results confirm that diets with a decreased SFA content reduce total cholesterol and LDL-cholesterol. A novel finding of the present study is evidence to suggest that reductions in the GI of the diet were associated with greater reductions in total cholesterol (P = 0.011) and LDL-cholesterol (P = 0.028). Importantly, NSP intake did not differ significantly between the HGI (HM-HGI and LF-HGI) and LGI groups (HM-LGI and LF-LGI) suggesting that the effect of GI is independent of the effects of dietary fibre. In the present study the most favourable change in total cholesterol :HDL-cholesterol was noted for the HM-LGI diet. The finding in the present study is in agreement with that of a recent meta-analysis (3) but indicates that a reduction in GI also contributes independently to a reduction in total cholesterol and LDL-cholesterol.
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